Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
Authors
Keywords
-
Journal
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 325, Issue 16, Pages 1620
Publisher
American Medical Association (AMA)
Online
2021-03-18
DOI
10.1001/jama.2021.4152
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
- (2021) Adam Cuker et al. Blood Advances
- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
- (2020) Dominic Wichmann et al. ANNALS OF INTERNAL MEDICINE
- COVID-19 and its implications for thrombosis and anticoagulation
- (2020) Jean Marie Connors et al. BLOOD
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19
- (2020) Ishan Paranjpe et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
- (2020) Behnood Bikdeli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Heparin resistance in COVID-19 patients in the intensive care unit
- (2020) D. White et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
- (2020) Geoffrey D. Barnes et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
- (2020) Matthew J Cummings et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
- (2020) Mahesh V. Madhavan et al. THROMBOSIS AND HAEMOSTASIS
- COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
- (2020) Hanny Al-Samkari et al. BLOOD
- Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019
- (2020) Lisa K. Moores et al. CHEST
- Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System
- (2020) Seda Bilaloglu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Coagulation abnormalities and thrombosis in patients with COVID-19
- (2020) Marcel Levi et al. Lancet Haematology
- COVID-19 is, in the end, an endothelial disease
- (2020) Peter Libby et al. EUROPEAN HEART JOURNAL
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence
- (2020) Behnood Bikdeli THROMBOSIS RESEARCH
- The management of venous thromboembolism in hospitalized patients with COVID-19
- (2020) Alex C. Spyropoulos Blood Advances
- Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19
- (2020) Nicholas S. Hendren et al. CIRCULATION
- Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19
- (2020) Gregory Piazza et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
- (2020) Anna Cristina Bertoldi Lemos et al. THROMBOSIS RESEARCH
- Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
- (2020) Behnood Bikdeli et al. THROMBOSIS RESEARCH
- Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019
- (2020) David Jiménez et al. CHEST
- Optimal Timing and Early Intervention With Anticoagulant Therapy for Sepsis-Induced Disseminated Intravascular Coagulation
- (2019) Kazuma Yamakawa et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Intermediate Dose Low-Molecular-Weight Heparin for Thrombosis Prophylaxis: Systematic Review with Meta-Analysis and Trial Sequential Analysis
- (2019) Ruben J. Eck et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- The Impact of Once- versus Twice-Daily Enoxaparin Prophylaxis on Risk for Venous Thromboembolism and Clinically Relevant Bleeding
- (2018) Christopher J. Pannucci et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Standardized Bleeding Definitions for Cardiovascular Clinical Trials
- (2011) Roxana Mehran et al. CIRCULATION
- Dalteparin versus Unfractionated Heparin in Critically Ill Patients
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started